Pursuant to Regulation 30 of the SEBI[LODR], Regulation, 2015, please find enclosed the transcript of the conference call for the quarter ended December 31, 2024, conducted after the meeting of the Board of Directors held on January 30, 2025.

pdf

Indegene Ltd.

31 Jan 2025

586.40

0.91%

Earnings Call

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 and 46(2)(o) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Q3FY25 earnings call, conducted on January 31,2025 is attached.

pdf

Indegene Ltd.

31 Jan 2025

586.40

0.91%

Indegene Results Earnings Call for Q3FY25

Conference Call with Indegene Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Indegene Ltd.

30 Jan 2025

586.40

0.91%

Investor Presentation

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI [LODR] Regulation, 2015, the Analyst presentation and fact sheet for the Q3FY25 with respect to financial results for the quarter ended December 31, 2024 are hereby enclosed.

pdf

Indegene Ltd.

04 Nov 2024

586.40

0.91%

Earnings Call

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI[LODR] Regulations, 2015, Please find enclosed the transcript of the conference call for the quarter ended September 30, 2024, conducted after the meeting of the Board of Directors held on October 28, 2024.